Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mesenchymal Stem/Stromal Cells as a Vehicle for Cytokine Delivery: An Emerging Approach for Tumor Immunotherapy.
Razeghian E, Margiana R, Chupradit S, Bokov DO, Abdelbasset WK, Marofi F, Shariatzadeh S, Tosan F, Jarahian M. Razeghian E, et al. Front Med (Lausanne). 2021 Aug 27;8:721174. doi: 10.3389/fmed.2021.721174. eCollection 2021. Front Med (Lausanne). 2021. Retraction in: Front Med (Lausanne). 2023 Sep 04;10:1285195. doi: 10.3389/fmed.2023.1285195 PMID: 34513882 Free PMC article. Retracted. Review.
Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges.
Razeghian E, Suksatan W, Sulaiman Rahman H, Bokov DO, Abdelbasset WK, Hassanzadeh A, Marofi F, Yazdanifar M, Jarahian M. Razeghian E, et al. Front Immunol. 2021 Aug 20;12:699746. doi: 10.3389/fimmu.2021.699746. eCollection 2021. Front Immunol. 2021. Retraction in: Front Immunol. 2023 Sep 04;14:1285126. doi: 10.3389/fimmu.2023.1285126 PMID: 34489946 Free PMC article. Retracted. Review.
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies.
Razeghian E, Nasution MKM, Rahman HS, Gardanova ZR, Abdelbasset WK, Aravindhan S, Bokov DO, Suksatan W, Nakhaei P, Shariatzadeh S, Marofi F, Yazdanifar M, Shamlou S, Motavalli R, Khiavi FM. Razeghian E, et al. Stem Cell Res Ther. 2021 Jul 28;12(1):428. doi: 10.1186/s13287-021-02510-7. Stem Cell Res Ther. 2021. PMID: 34321099 Free PMC article. Review.
Cloning and Embryo Splitting in Mammalians: Brief History, Methods, and Achievements.
Rahbaran M, Razeghian E, Maashi MS, Jalil AT, Widjaja G, Thangavelu L, Kuznetsova MY, Nasirmoghadas P, Heidari F, Marofi F, Jarahian M. Rahbaran M, et al. Among authors: razeghian e. Stem Cells Int. 2021 Nov 30;2021:2347506. doi: 10.1155/2021/2347506. eCollection 2021. Stem Cells Int. 2021. PMID: 34887927 Free PMC article. Review.
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons.
Naimi A, Mohammed RN, Raji A, Chupradit S, Yumashev AV, Suksatan W, Shalaby MN, Thangavelu L, Kamrava S, Shomali N, Sohrabi AD, Adili A, Noroozi-Aghideh A, Razeghian E. Naimi A, et al. Among authors: razeghian e. Cell Commun Signal. 2022 Apr 7;20(1):44. doi: 10.1186/s12964-022-00854-y. Cell Commun Signal. 2022. PMID: 35392976 Free PMC article. Review.